# Observational Studies: Cohort and Case-Control Studies

Author: Jae W. Song and Kevin C. Chung

[Origin](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2998589/)


## Introduction

+ Observational studies
  + category of study design
  + providing results similar to randomized control trials
  + challenging the belief

+ Evidence-based medicine (EBM)
  + levels of evidence based medicine

    <table frame="box" rules="all" class="rendered small default_table">
      <thead>
        <tr>
          <th align="left" valign="top" rowspan="1" colspan="1">Level of Evidence</th><th align="left" valign="top" rowspan="1" colspan="1">Qualifying Studies</th>
        </tr>
      </thead>
      <tbody>
        <tr>
          <td align="left" valign="top" rowspan="1" colspan="1">I</td><td align="left" valign="top" rowspan="1" colspan="1">High-quality, multicenter or single-center, randomized controlled trial with adequate power; or systematic review of these studies</td>
        </tr>
          <tr><td align="left" valign="top" rowspan="1" colspan="1">II</td><td align="left" valign="top" rowspan="1" colspan="1">Lesser quality, randomized controlled trial; prospective cohort study; or systematic review of these studies</td>
        </tr>
          <tr><td align="left" valign="top" rowspan="1" colspan="1">III</td><td align="left" valign="top" rowspan="1" colspan="1">Retrospective comparative study; case-control study; or systematic review of these studies</td>
        </tr>
        <tr>
          <td align="left" valign="top" rowspan="1" colspan="1">IV</td><td align="left" valign="top" rowspan="1" colspan="1">Case-series</td>
        </tr>
        <tr>
          <td align="left" valign="top" rowspan="1" colspan="1">V</td><td align="left" valign="top" rowspan="1" colspan="1">Expert opinion; case report or clinical example; or evidence based on physiology, bench research, or “first principles”</td>
        </tr>
      </tbody>
    </table>
  
  + randomized controlled trial (RCT) methodology
    + held the pre-eminent position in the hierarchy of EBM as level I evidence
    + developed for drug trials
    + difficulty for surgical investigations
  + observational studies
    + playing an important role in deriving evidence for plastic surgery
    + level II and III evidence in EBM
    + recent challenge: vulnerable to influence by unpredictable confounding factors
    + complement RCTs in hypothesis generation, establishing questions for further RCTs, and defining clinical, and clinical conditions

+ Analytic study designs
  + category of analytic study design (left diagram)
  + goal: to identify and evaluate causes or risk factors of diseases or health-related events
  + differences
    + experimental study:
      + the presence or absence of undergoing an intervention defining the groups
    + observational study:
      + simply observing and accessing the strength of the relationship btw and exposure and outcome (disease variable)
      + types of observational studies: cohort studies, case-control studies, and cross-sectional studies
      + case-control and cohort studies: measuring disease occurrence and its association w/ an exposure by offering a temporal dimension(i.e. prospective and retrospective study design)
      + cross-section / prevalence studies (right diagram)
        + examining the data on outcome and exposure at one particular time point
        + no temporal relationship btw disease occurrence and exposure
        + unable to assess the cause and effect relationship

  <div style="margin: 0.5em; display: flex; justify-content: center; align-items: center; flex-flow: row wrap;">
    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2998589/" ismap target="_blank">
      <img src="https://www.ncbi.nlm.nih.gov/corecgi/tileshop/tileshop.fcgi?p=PMC3&id=761954&s=23&r=1&c=1" style="margin: 0.1em;" alt="Analytic Study Design" title="Analytic Study Design" width=400>
      <img src="https://www.ncbi.nlm.nih.gov/corecgi/tileshop/tileshop.fcgi?p=PMC3&id=761958&s=23&r=1&c=1" style="margin: 0.1em;" alt="Temporal Design of Observational Studies: Cross-sectional studies are known as prevalence studies and do not have an inherent temporal dimension." title="Temporal Design of Observational Studies: Cross-sectional studies are known as prevalence studies and do not have an inherent temporal dimension." width=300>
    </a>
  </div>


## Cohort Study




### Study design





### Methodological issues





## Case-control Study





### Study design





### Methodological issues






## The STROBE Statement




## Conclusion




## References

1. Chung KC, Swanson JA, Schmitz D, et al. [Introducing evidence-based medicine to plastic and reconstructive surgery](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2714535/). Plast. Reconstr. Surg. 2009;123:1385–1389.
2. Hulley SB, Cummings SR, Browner WS, et al. [Designing Clinical Research: An Epidemiologic Approach](https://scholar.google.com/scholar_lookup?title=Designing+Clinical+Research:+An+Epidemiologic+Approach&author=SB+Hulley&author=SR+Cummings&author=WS+Browner&publication_year=2001&). 2nd Ed Lippincott Williams & Wilkins; Philadelphia: 2001. pp. 1–336.
3. Chung KC, Burns PB. [A guide to planning and executing a surgical randomized controlled trial](https://www.ncbi.nlm.nih.gov/pubmed/18343300). J. Hand Surg. [Am] 2008;33:407–412.
4. Benson K, Hartz AJ. [A comparison of observational studies and randomized, controlled trials](https://www.ncbi.nlm.nih.gov/pubmed/10861324). N. Engl. J. Med. 2000;342:1878–1886.
5. Concato J, Shah N, Horwitz RI. [Randomized, controlled trials, observational studies, and the hierarchy of research designs](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557642/). N. Engl. J. Med. 2000;342:1887–1892.
6. Merril RM, Timmreck TC. [Introduction to Epidemiology](https://scholar.google.com/scholar_lookup?title=Introduction+to+Epidemiology&author=RM+Merril&author=TC+Timmreck&publication_year=2006&). 4th Ed Jones and Bartlett Publishers; Mississauga, Ontario: 2006. pp. 1–342. 
7. Morabia A. [A History of Epidemiologic Methods and Concepts](https://scholar.google.com/scholar_lookup?title=A+History+of+Epidemiologic+Methods+and+Concepts&author=A+Morabia&publication_year=2004&). Birkhaeuser Verlag; Basel: 2004. pp. 1–405.
8. Everitt BS, Palmer CR. [Encyclopaedic Companion to Medical Statistics](https://scholar.google.com/scholar_lookup?title=Encyclopaedic+Companion+to+Medical+Statistics&author=BS+Everitt&author=CR+Palmer&publication_year=2005&). Hodder Arnold; London: 2005. 
9. Elwood M. [Critical Appraisal of Epidemiological Studies and Clinical Trials](https://scholar.google.com/scholar_lookup?title=Critical+Appraisal+of+Epidemiological+Studies+and+Clinical+Trials&author=M+Elwood&publication_year=2007&). 3rd Ed Oxford University Press; Oxford: 2007. pp. 1–570. 
10. Framingham Heart Study. [Framingham Heart Study. A Project of the National Heart, Lung, Blood Institute and Boston University](http://www.framinghamheartstudy.org/index.html). Accessed January 21, 2010.
11. Spear SL, Ducic I, Cuoco F, et al. [Effect of obesity on flap and donor-site complications in pedicled TRAM flap breast reconstruction](https://www.ncbi.nlm.nih.gov/pubmed/17312479). Plast. Reconstr. Surg. 2007;119:788–795.
12. Jenicek M. [Foundations of Evidence-Based Medicine](https://scholar.google.com/scholar_lookup?title=Foundations+of+Evidence-Based+Medicine&author=M+Jenicek&publication_year=2003&). Parthenon Pub. Group; Boca Raton: 2003. pp. 1–542.
13. Lane-Claypon JE. [A further Report on Cancer of the Breast, with Special Reference to its Associated Antecedent Conditions](https://scholar.google.com/scholar_lookup?journal=A+further+Report+on+Cancer+of+the+Breast,+with+Special+Reference+to+its+Associated+Antecedent+Conditions&author=JE+Lane-Claypon&publication_year=1926&). 1926
14. Cole P. [The evolving case-control study](https://www.ncbi.nlm.nih.gov/pubmed/312804). J. Chronic Dis. 1979;32:15–27.
15. Doll R, Hill AB. [Smoking and carcinoma of the lung; preliminary report](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2038856/). Br. Med. J. 1950;2:739–748.
16. Zhang QG, Zhang J, Yu P, et al. [Environmental and genetic factors associated with congenital microtia: A case-control study in Jiangsu](https://www.ncbi.nlm.nih.gov/pubmed/19935299), China, 2004 to 2007. Plast. Reconstr. Surg. 2009;124:1157–1164.
17. Suutarla S, Rautio J, Ritvanen A, et al. [Microtia in Finland: Comparison of characteristics in different populations](https://www.ncbi.nlm.nih.gov/pubmed/17548114). Int. J. Pediatr. Otorhinolaryngol. 2007;71:1211–1217.
18. Chung KC, Kowalski CP, Kim HM, et al. [Maternal cigarette smoking during pregnancy and the risk of having a child with cleft lip/palate](https://www.ncbi.nlm.nih.gov/pubmed/10697150). Plast. Reconstr. Surg. 2000;105:485–491.
19. Das SK, Runnels RS, Jr, Smith JC, et al. [Epidemiology of cleft lip and cleft palate in Mississippi](https://www.ncbi.nlm.nih.gov/pubmed/7716597). South. Med. J. 1995;88:437–442.
20. Wacholder S, McLaughlin JK, Silverman DT, et al. [Selection of controls in case-control studies. I. principles](https://www.ncbi.nlm.nih.gov/pubmed/1595688). Am. J. Epidemiol. 1992;135:1019–1028.
21. Ury HK. [Efficiency of case-control studies with multiple controls per case: Continuous or dichotomous data](https://www.ncbi.nlm.nih.gov/pubmed/1100136). Biometrics. 1975;31:643–649.
22. Bruce N, Pope D, Stanistreet D. [Quantitative Methods for Health Research](https://scholar.google.com/scholar_lookup?title=Quantitative+Methods+for+Health+Research&author=N+Bruce&author=D+Pope&author=D+Stanistreet&publication_year=2008&). John Wiley & Sons, Ltd; West Sussex, England: 2008. pp. 1–529.
23. Woodward M. [Epidemiology: Study Design and Data Analysis](https://scholar.google.com/scholar_lookup?title=Epidemiology:+Study+Design+and+Data+Analysis&author=M+Woodward&publication_year=2005&). 2nd Ed Chapman & Hall/CRC; London: 2005. pp. 1–849.
24. Vandenbroucke JP. [The making of STROBE](https://scholar.google.com/scholar_lookup?journal=Epidemiology&title=The+making+of+STROBE&author=JP+Vandenbroucke&volume=18&publication_year=2007&pages=797-799&pmid=18049193&). Epidemiology. 2007;18:797–799.
25. von Elm E, Altman DG, Egger M, et al. [The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies](https://www.ncbi.nlm.nih.gov/pubmed/18313558). J. Clin. Epidemiol. 2008;61:344–349.
26. von Elm E, Altman DG, Egger M, et al. [The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies](https://www.ncbi.nlm.nih.gov/pubmed/18064739). Lancet. 2007;370:1453–1457.
27. Vandenbroucke JP, von Elm E, Altman DG, et al. [Strengthening the reporting of observational studies in epidemiology (STROBE): Explanation and elaboration](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2020496/). PLoS Med. 2007;4:e297.


